A theme concerning the impact on consolidated results of the cost burden associated with capital investment at overseas sites, research and development of new products and technologies, and investment in automated processes and DX initiatives. It addresses the impact of the investments and research and development expenses themselves on results, rather than risks involving failure to recover the investments or failure to achieve the required equipment capacity.